Home/Filings/4/0001209191-16-111161
4//SEC Filing

aTYR PHARMA INC 4

Accession 0001209191-16-111161

$ATYRCIK 0001339970operating

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 9:00 PM ET

Size

5.6 KB

Accession

0001209191-16-111161

Insider Transaction Report

Form 4
Period: 2016-03-28
Blackburn Kelly
See Remarks
Transactions
  • Award

    Restricted Stock Unit

    2016-03-28+21,60021,600 total
    Common Stock (21,600 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]1/2 of the restricted stock units are scheduled to vest on March 28, 2017 and the remaining 1/2 are scheduled to vest on March 28, 2018. This grant is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.

Issuer

aTYR PHARMA INC

CIK 0001339970

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001339970

Filing Metadata

Form type
4
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 9:00 PM ET
Size
5.6 KB